ROS1-rearranged putative lung adenocarcinoma presenting as carcinoma of unknown primary site: a case report.

In conclusion, putative lung adenocarcinoma presenting as CUP may involve ROS1 rearrangement, and ROS1 inhibitor therapy may be effective. PMID: 30443294 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/30443294?dopt=Abstract

Source: Oncotarget - November 19, 2018 Category: Cancer & Oncology Tags: Oncotarget Source Type: research